Promising strides in Ovarian Cancer research! – Henry Rodriguez

Promising strides in Ovarian Cancer research! CPTAC has identified a 64-protein signature that may predict which patients do not respond to chemotherapy. This novel protein signature may save patients from unnecessary toxic side effects and is a promising step toward personalized therapy and better outcomes.

For the article: Click here
Source: Henry Rodriguez / Linkedin